Technology Business of the YearBack to Winners

Sponsored by Cripps & University of Kent

eXroid Technology Ltd

The team at eXroid Technology Ltd has been helping thousands of haemorrhoid sufferers for years – harnessing a clever device to make a big difference. device to make a big difference.

It believes its treatment is transformational in its benefits for patients – with some describing it as “life changing”. It is only too aware that talking about haemorrhoids can be difficult given its sensitive nature, but its experienced haemorrhoid advisors are on hand to help answer questions and concerns.

Based at Sandwich’s Discovery Park, and registered with the Care Quality Commission (CQC), its services and clinics are available across the country. It also provides access to some of the leading colorectal specialist consultants in the country.

As a certified medical device manufacturer, its treatment is based on the cutting-edge technology it has developed and which forms the basis of its treatment plan. It involves a probe being placed on the base of the haemorrhoids which generates a small current which stimulates a chemical reaction. It creates an excess of alkali which accumulates to seal off the feeding varicose blood vessel. Starved of its blood supply, the haemorrhoid shrinks accordingly. It involves no cutting, stitching or heat being applied which means no anaesthetic. As such it is a low risk treatment.

It has undergone rigorous regulatory review from prototyping through to validation testing of electronics, microbiology, radiation, transit, and a full quality management system assessment for compliance.

The build and regulatory requirements needed to release the device to market as a usable technology took over two years to pass a rigorous set of standards, audits, and tests. It works with manufacturing partners both in the UK and Taiwan which are audited by the firm and its regulator to ensure strict protocols and standards of production are being met.

The firm currently has a patent-pending application for the next stage of development of the device, covering more than 130 territories.

It has also ushered in a major system overhaul to include a new clinical booking system which allows the doctors in its clinics to access via a tablet – making patient records paper-free, secure and trackable as well as a new patient CRM database.

Finalists